China Pharma Holdings Inc (CPHI) — Working Capital to Net Assets Ratio
China Pharma Holdings Inc (CPHI) has a Working Capital to Net Assets ratio of -50.5% as of September 2025. Working capital of $-4.29 Million (current assets of $2.33 Million minus current liabilities of $6.62 Million) is measured against net assets of $8.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See China Pharma Holdings Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
China Pharma Holdings Inc Working Capital to Net Assets (2001–2024)
This chart shows how China Pharma Holdings Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the ratio stands at -50.5%, reflecting working capital of $-4.29 Million against net assets of $8.49 Million USD. See China Pharma Holdings Inc (CPHI) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for China Pharma Holdings Inc (2001–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for China Pharma Holdings Inc from 2001 to 2024, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see China Pharma Holdings Inc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -22.5% | $-1.75 Million | $7.75 Million | $3.27 Million | $5.02 Million | ▼ -11.5 pp |
| 2023 | -11.0% | $-823.73K | $7.45 Million | $6.00 Million | $6.82 Million | ▲ +146.9 pp |
| 2022 | -157.9% | $-6.77 Million | $4.29 Million | $5.96 Million | $12.74 Million | ▼ -134.3 pp |
| 2021 | -23.6% | $-1.42 Million | $6.02 Million | $9.09 Million | $10.51 Million | ▲ +52.4 pp |
| 2020 | -76.0% | $-6.08 Million | $8.00 Million | $5.32 Million | $11.40 Million | ▼ -27.6 pp |
| 2019 | -48.3% | $-4.47 Million | $9.24 Million | $5.58 Million | $10.05 Million | ▼ -44.0 pp |
| 2018 | -4.3% | $-1.30 Million | $30.20 Million | $8.75 Million | $10.05 Million | ▼ -11.4 pp |
| 2017 | 7.1% | $3.06 Million | $43.07 Million | $12.29 Million | $9.23 Million | ▼ -5.0 pp |
| 2016 | 12.1% | $7.12 Million | $58.91 Million | $17.52 Million | $10.40 Million | ▼ -4.7 pp |
| 2015 | 16.7% | $12.17 Million | $72.64 Million | $24.96 Million | $12.79 Million | ▼ -21.2 pp |
| 2014 | 37.9% | $40.32 Million | $106.25 Million | $54.49 Million | $14.17 Million | ▼ -16.2 pp |
| 2013 | 54.1% | $71.95 Million | $132.94 Million | $83.96 Million | $12.01 Million | ▼ -11.8 pp |
| 2012 | 65.9% | $97.90 Million | $148.52 Million | $112.53 Million | $14.63 Million | ▼ -2.0 pp |
| 2011 | 68.0% | $96.83 Million | $142.48 Million | $110.61 Million | $13.78 Million | ▲ +0.9 pp |
| 2010 | 67.1% | $79.13 Million | $117.94 Million | $91.93 Million | $12.81 Million | ▼ -0.2 pp |
| 2009 | 67.3% | $60.79 Million | $90.40 Million | $71.30 Million | $10.51 Million | ▼ -10.3 pp |
| 2008 | 77.5% | $54.16 Million | $69.87 Million | $59.73 Million | $5.57 Million | ▼ -10.3 pp |
| 2007 | 87.8% | $34.92 Million | $39.76 Million | $38.83 Million | $3.91 Million | ▲ +1.1 pp |
| 2006 | 86.7% | $18.07 Million | $20.85 Million | $25.71 Million | $7.63 Million | ▼ -13.3 pp |
| 2005 | 100.0% | $-68.32K | $-68.32K | $84.00 | $68.41K | ▲ +0.0 pp |
| 2004 | 100.0% | $-68.32K | $-68.32K | $84.00 | $68.41K | ▼ -22.9 pp |
| 2003 | 122.9% | $-902.26K | $-733.96K | $3.55K | $905.82K | ▲ +4.7 pp |
| 2002 | 118.2% | $-669.63K | $-566.35K | $3.84K | $673.47K | ▲ +0.0 pp |
| 2001 | 118.2% | $-669.63K | $-566.35K | $3.84K | $673.47K | — |